Technochrom FVIII:C 2G

Professional-grade IVD kit for accurate FVIII:C measurement in hemophilia A diagnosis and treatment monitoring

Technochrom FVIII:C 2G is an in vitro diagnostic (IVD) reagent kit designed for the quantitative measurement of coagulation Factor VIII (FVIII:C) activity, standardized according to WHO guidelines, using a chromogenic method.

This assay is a critical tool for the diagnosis of hemophilia A, the detection of Factor VIII deficiency, the monitoring of replacement therapies (including emicizumab prophylaxis), and the quantification of FVIII concentrates in clinical practice.

✅ Indications and Clinical Applications

Congenital or acquired Factor VIII deficiencies
Investigation of prolonged activated partial thromboplastin time (aPTT)
Evaluation of FVIII activity in von Willebrand disease
Monitoring of extended half-life FVIII replacement therapies
Measurement of FVIII activity in the presence of emicizumab
Assessment of elevated FVIII levels in patients at thrombotic risk

Advantages

High specificity and sensitivity
WHO-standardized quantification
Reduced susceptibility to interference (e.g., lupus anticoagulants, heparin)
Suitable for non-factor therapies and gene therapy follow-up
Complies with international hemophilia diagnosis guidelines

Analyzer Compatibility

Optimized for Ceveron 100 series analyzers
Compatible with other validated chromogenic platforms (manual or automated)
Measurement conditions: 37 °C, 405 nm

Documentation

Download the product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

References

Substrate (2 x 10 mL): Z-D-Arg-Gly-Arg-pNA
Reagent A (2 x 2 mL): Phospholipids, BSA, heparin neutralizer
Reagent B (2 x 2 mL): FIXa (human), FX (bovine), FIIa (human), calcium
Format: 80 tests per kit

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE REAGENTS

HEMOSTASIS COAGULATION ROUTINE REAGENTS FACTOR ASSAYS CHROMOGENIC ASSAYS FACTOR VIII

HEMOSTASIS COAGULATION ROUTINE REAGENTS FACTOR ASSAYS

HEMOSTASIS COAGULATION ROUTINE REAGENTS FACTOR ASSAYS CHROMOGENIC ASSAYS